A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer

Cancer Chemotherapy and Pharmacology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/1S5VCIc
via IFTTT